S 832
Who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Gave to its sponsors8 of 30
III, Henry L. Collins$92KJeffrey Steinkamp.$35KClayton Mobley$30KMatt Mills$30KAlbert, Clark$29KDonald Sodaro$29KMichael L. Parin$25KIlias Lou Moshakos$23KSponsors7 cosponsors more
Thom TillisCongress · North Carolina · RS 832
EPIC Act of 2025
Congress · In committee
Lobbied on it8 of 23
Pharmaceutical Research and Manufacturers of America25 reportsNovartis21 reportsBayer Corporation (Consolidated Report)10 reportsDla Piper LLP (US)10 reportsEmd Serono, Inc.10 reportsGSK (Fka Glaxosmithkline Inc.)10 reportsHealthcare Institute of New Jersey10 reportsJohnson & Johnson Services Inc10 reportsEvery link on this map
The same connections as a table, with the reason each one is here.
| III, Henry L. Collins | Gave to its sponsors | III, Henry L. Collins gave $92K to a sponsor of S 832. A gift is not a position on the bill. | $92K |
| Jeffrey Steinkamp. | Gave to its sponsors | Jeffrey Steinkamp. gave $35K to a sponsor of S 832. A gift is not a position on the bill. | $35K |
| Clayton Mobley | Gave to its sponsors | Clayton Mobley gave $30K to a sponsor of S 832. A gift is not a position on the bill. | $30K |
| Matt Mills | Gave to its sponsors | Matt Mills gave $30K to a sponsor of S 832. A gift is not a position on the bill. | $30K |
| Albert, Clark | Gave to its sponsors | Albert, Clark gave $29K to a sponsor of S 832. A gift is not a position on the bill. | $29K |
| Donald Sodaro | Gave to its sponsors | Donald Sodaro gave $29K to a sponsor of S 832. A gift is not a position on the bill. | $29K |
| Michael L. Parin | Gave to its sponsors | Michael L. Parin gave $25K to a sponsor of S 832. A gift is not a position on the bill. | $25K |
| Ilias Lou Moshakos | Gave to its sponsors | Ilias Lou Moshakos gave $23K to a sponsor of S 832. A gift is not a position on the bill. | $23K |
| Thom Tillis | Sponsors | Thom Tillis sponsored S 832. | None |
| Pharmaceutical Research and Manufacturers of America | Lobbied on it | Pharmaceutical Research and Manufacturers of America named S 832 in 25 lobbying reports. | 25 reports |
| Novartis | Lobbied on it | Novartis named S 832 in 21 lobbying reports. | 21 reports |
| Bayer Corporation (Consolidated Report) | Lobbied on it | Bayer Corporation (Consolidated Report) named S 832 in 10 lobbying reports. | 10 reports |
| Dla Piper LLP (US) | Lobbied on it | Dla Piper LLP (US) named S 832 in 10 lobbying reports. | 10 reports |
| Emd Serono, Inc. | Lobbied on it | Emd Serono, Inc. named S 832 in 10 lobbying reports. | 10 reports |
| GSK (Fka Glaxosmithkline Inc.) | Lobbied on it | GSK (Fka Glaxosmithkline Inc.) named S 832 in 10 lobbying reports. | 10 reports |
| Healthcare Institute of New Jersey | Lobbied on it | Healthcare Institute of New Jersey named S 832 in 10 lobbying reports. | 10 reports |
| Johnson & Johnson Services Inc | Lobbied on it | Johnson & Johnson Services Inc named S 832 in 10 lobbying reports. | 10 reports |